Laura Chico Stock Analyst Profile - Wedbush Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Laura Chico

    Stock Analyst at Wedbush

    (5)
    # 434
    Out of 5,506 analysts
    281
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare Consumer Cyclical
    Top Industries:
    Biotechnology Drug Manufacturers - General Drug Manufacturers - Specialty & Generic

    50 Stocks

    Name Action PT Current % Upside Ratings Updated
    LRMR Larimar Therapeutics
    Maintains: Outperform
    15 11
    		4.87 125.87% 3 Sep 30, 2025
    PEPG PepGen
    Maintains: Outperform
    9 8
    		5.13 55.95% 12 Sep 30, 2025
    DNTH Dianthus Therapeutic...
    Maintains: Outperform
    42 44
    		34.94 25.93% 9 Sep 12, 2025
    TRML Tourmaline Bio
    Downgrades: Neutral
    48 48
    		47.9 0.21% 3 Sep 9, 2025
    JBIO Jade Biosciences
    Maintains: Outperform
    17 18
    		n/a n/a 3 Aug 14, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    17 14
    		5.9 137.29% 3 Aug 13, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    16 22
    		25.56 -13.93% 7 Aug 13, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    42 43
    		39.61 8.56% 9 Aug 12, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    30 32
    		24.64 29.87% 12 Aug 7, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    4 5
    		2.57 94.55% 6 Aug 6, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    13 14
    		5.26 166.16% 14 Aug 5, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    137 141
    		137.03 2.9% 10 Jul 31, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    35 34
    		31.21 8.94% 13 Jul 14, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    17
    		27.11 -37.29% 1 Jul 8, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    16 18
    		7.15 151.75% 1 Jun 30, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Neutral
    130 130
    		130.06 -0.05% 1 Jun 18, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Neutral
    121 121
    		159.88 -24.32% 18 Jun 12, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Outperform
    27 27
    		23.39 15.43% 7 Jun 5, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    13 8
    		n/a n/a 11 May 22, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Neutral
    4 4
    		6.9 -42.03% 4 May 15, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    32 30
    		15.42 94.55% 8 May 7, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    34 26
    		30.14 -13.74% 8 May 7, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Underperform
    26 28
    		54.38 -48.51% 7 May 5, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    43 43
    		15.65 174.76% 10 Apr 21, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    4 3
    		1.84 63.04% 2 Mar 12, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    27 28
    		7.52 272.34% 9 Mar 12, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    30 29
    		23.8 21.85% 14 Mar 3, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Neutral
    6 6
    		n/a n/a 9 Feb 12, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    40 44
    		n/a n/a 7 Sep 17, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    8 7
    		4.86 44.03% 4 Aug 7, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Outperform
    42 42
    		21.65 94% 7 Jul 29, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Outperform
    1435 1435
    		n/a n/a 3 Jun 6, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    13 11
    		0.56 1864.29% 4 Apr 11, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Neutral
    5
    		6.11 -18.17% 5 Mar 20, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    330
    		n/a n/a 6 Dec 22, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Market Perform
    n/a
    		n/a n/a 5 Sep 28, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    42
    		n/a n/a 3 Aug 8, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    24 5
    		n/a n/a 2 Nov 15, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    9 5
    		4.76 5.04% 2 Aug 12, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    149
    		15.81 839.28% 1 Aug 8, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    16
    		n/a n/a 1 Sep 2, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 4 Feb 8, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    33
    		n/a n/a 1 Sep 18, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reinstates: Outperform
    40
    		n/a n/a 3 Feb 15, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Market Perform
    240 0
    		n/a n/a 2 Sep 12, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Outperform
    36 0
    		n/a n/a 2 Mar 2, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Market Perform
    n/a
    		n/a n/a 2 Jan 23, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    720
    		14.83 4755.02% 1 Jan 19, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Underperform
    n/a
    		n/a n/a 1 Nov 16, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Strong Buy
    280
    		101.99 174.54% 1 Apr 21, 2017